The opening price for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was $36.06 and the volume amounted to 1.24 million shares which compares with the average volume of 1.41 million shares. The company stock experienced a 2.47% move to arrive at $36.99.ACADIA Pharmaceuticals Inc. (ACAD) Analyst Opinion
ACADIA Pharmaceuticals Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 5.33% of shares outstanding. The stock spiked 0.03% last month and is up 28.26 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover ACAD having a buy-equivalent rating. Analysts have placed a $49.11 price target on ACADIA Pharmaceuticals Inc., suggesting a 32.77% gain from recent close. It’s currently trading about -10.22% below its 52-week high.ACADIA Pharmaceuticals Inc. Earnings Surprise
ACADIA Pharmaceuticals Inc. (ACAD) surprised the stock market in its last reported earnings when it earned -$0.55 a piece versus the consensus-estimated -$0.72. Its revenue totaled $20.02 million up 30.94% from the previous quarter.ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Intraday View
This stock (ACAD) is ahead of its 52-week low with 78.87%. Its last month’s stock price volatility remained 3.18% which for the week stands at 3.34%. The share price has moved backward from its 20 days moving average, trading at a distance of -1.12% and stays 5.18% away from its 50 days moving average. Over the last five days, shares have managed 0.22% gains and now is up 12.86% since hitting its 200-day moving average of $31.67. ACADIA Pharmaceuticals Inc. (ACAD) has made its way to a 12-month gain of 52.07%.
Turning to Huntsman Corporation (NYSE:HUN), its shares were trading at $29.2 a gain of $0.11, on the trading floor. The stock, after opening at $28.96, touched a high of $29.26 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Huntsman Corporation has 3 buy ratings, 0 holds and 0 sells even after the stock tumbled -0.79% from its high of $29.43 to a $6.75 billion market value through last close.Huntsman Corporation (HUN) Consensus Price Target
The company’s consensus rating on Reuter’s scale slipped from 1.89 to 1.67 during a month. Analysts set a 12-month price target of $32.33 a share. The target implies a 10.72% spike from where the shares are currently trading. Also, the current price highlights a discount of 16.44% to analysts’ high consensus price target.Huntsman Corporation (NYSE:HUN) Intraday Trading
The counter witnessed a trading volume of 3.77 million shares versus an average volume of 2.71 million shares during last trading session. Its last month’s stock price volatility remained 2.23% which for the week approaches 1.83%. The lowest price the stock reached in the last trading day was $28.88 and compares with the $15.62 52-week low. The stock recovered 86.94% since its low point and has performed 53.04% year-to-date.